# Plain Language Summary: Expanded Genetic Screening Act of 2021

This bill would require Medicaid to pay for genetic screening tests for pregnant women. Specifically, it covers non-invasive prenatal genetic screening, which means tests that don't involve any risk to the pregnancy—like blood tests that can check for certain genetic conditions in the fetus. Right now, Medicaid coverage for these tests varies by state and situation, and many pregnant women have to pay out of pocket or fight with their insurance to get coverage. This bill would make it a guaranteed benefit for all Medicaid-eligible pregnant women, regardless of their age.

The practical impact is straightforward: pregnant women on Medicaid would be able to get genetic screening tests without worrying about the cost. These tests can detect conditions like Down syndrome and other chromosomal abnormalities early in pregnancy, giving families important information to prepare for their child's birth or make decisions about their pregnancy. The tests can be done in a doctor's office, a clinic, at home, or other settings, so it's about access and affordability rather than changing how the tests work.

This matters most for lower-income pregnant women who rely on Medicaid for their healthcare. Currently, whether they can get these tests often depends on which state they live in and their individual circumstances. By making it a standard Medicaid benefit nationwide, the bill would ensure that financial barriers don't prevent pregnant women from accessing information about their baby's health. The bill doesn't force anyone to get the screening—it simply makes sure that if a pregnant woman and her doctor decide it's appropriate, Medicaid will cover the cost.

Expanded Genetic Screening Act of 2021

Speier, Jackie

Expanded Genetic Screening Act of 2021 This bill requires state Medicaid programs to cover noninvasive prenatal genetic screening for pregnant women. (Noninvasive prenatal genetic screening uses naturally occurring fetal DNA from the mother's blood to screen for genetic abnormalities.)